MedTrace Logo

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

NCT00865007 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2013-03-22

No results posted yet for this study

Summary

The aim of this study is to evaluate the efficacy for the recovery of peripheral fat of lopinavir/ritonavir in monotherapy versus abacavir/lamivudine and lopinavir/ritonavir in subjects who developed lipoatrophy while receiving zidovudine plus lamivudine plus abacavir.

Conditions

  • HIV Infection
  • Lipodystrophy
  • HIV Infections

Interventions

DRUG

Monotherapy (Lopinavir/ritonavir)

NRTI sparing

DRUG

Monotherapy (Lopinavir/ritonavir) + ABC/3TC

NRTI sparing regimen

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Fundacion SEIMC-GESIDA

    lead OTHER

Principal Investigators

  • Jose Ignacio Bernardino · Hospital La Paz

  • Jose Ramon Arribas · Hospital La Paz

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-06-30
Completion
2012-09-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00865007 on ClinicalTrials.gov